These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 8743334

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
    Iwaki T, Hirabayashi N, Miyazawa N, Takeuchi Y, Ishizaki K, Sakakura H, Kasai H, Maeda M, Araki T.
    Eur J Pharmacol; 1998 Dec 11; 363(1):41-8. PubMed ID: 9877080
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
    Colombo C, Crosignani A, Alicandro G, Zhang W, Biffi A, Motta V, Corti F, Setchell KDR.
    J Pediatr; 2016 Oct 11; 177():59-65.e1. PubMed ID: 27297203
    [Abstract] [Full Text] [Related]

  • 27. Bioequivalence of a new liquid formulation of ursodeoxycholic acid (Ursofalk suspension) and Ursofalk capsules measured by plasma pharmacokinetics and biliary enrichment.
    Setchell KD, Galzigna L, O'Connell N, Brunetti G, Tauschel HD.
    Aliment Pharmacol Ther; 2005 Mar 15; 21(6):709-21. PubMed ID: 15771757
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Formation, absorption, and biotransformation of delta 6-lithocholenic acid in humans.
    Malavolti M, Fromm H, Nsien E, Setchell KD, Albert MB, Cohen B, Ceryak S.
    Am J Physiol; 1993 Jan 15; 264(1 Pt 1):G163-71. PubMed ID: 8430800
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
    Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD.
    Hepatology; 1991 Jun 15; 13(6):1076-83. PubMed ID: 2050325
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Synthesis of 13C-labeled chenodeoxycholic, hyodeoxycholic, and ursodeoxycholic acids for the study of bile acid metabolism in liver disease.
    Matern S, Marschall HU, Schill A, Schumacher B, Lehnert W, Sjövall J, Matern H.
    Clin Chim Acta; 1991 Nov 09; 203(1):77-89. PubMed ID: 1769122
    [Abstract] [Full Text] [Related]

  • 37. Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
    Iwaki T, Ishizaki K, Kinoshita S, Tanaka H, Fukunari A, Tsurufuji M, Imada T.
    World J Gastroenterol; 2007 Oct 07; 13(37):5003-8. PubMed ID: 17854144
    [Abstract] [Full Text] [Related]

  • 38. Metabolism of 7 beta-alkyl chenodeoxycholic acid analogs and their effect on cholesterol metabolism in hamsters.
    Une M, Yamanaga K, Mosbach EH, Tsujimura K, Hoshita T.
    J Lipid Res; 1990 Jun 07; 31(6):1015-21. PubMed ID: 2373951
    [Abstract] [Full Text] [Related]

  • 39. Hepatic biotransformation and choleretic effect of 7-ketolithocholic acid in the rat.
    Kanai S, Sato Y, Nokubo M, Kitani K.
    Lipids; 1989 Oct 07; 24(10):859-65. PubMed ID: 2811609
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.